N@N

Array BioPharma to Present at the Lazard Annual Healthcare and Jefferies 2012 Global Healthcare Conferences

  //health-fitness.news-articles.net/content/2012/ .. efferies-2012-global-healthcare-conferences.html
  Published in Health and Fitness on Wednesday, November 7th 2012 at 12:31 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

Array BioPharma to Present at the Lazard Annual Healthcare and Jefferies 2012... -- BOULDER, Colo., Nov. 7, 2012 /PRNewswire/ --

[ ]

[ Download image ]

BOULDER, Colo., Nov. 7, 2012 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: [ ARRY ]) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences.  The public is welcome to participate in the conferences through webcasts on the Array BioPharma website:  [ www.arraybiopharma.com ].   

(Logo:  [ http://photos.prnewswire.com/prnh/20121029/LA02195LOGO ])

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small‑molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two wholly‑owned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune / Roche), having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013.  For more information on Array, please go to [ www.arraybiopharma.com ].

CONTACT: Tricia Haugeto 
Array BioPharma Inc.
303-386-1193
[ thaugeto@arraybiopharma.com ]

SOURCE Array BioPharma Inc.